Member of the Association of American Physicians
His primary areas of investigation include Immunology, Internal medicine, Virology, Pre-exposure prophylaxis and Men who have sex with men. The study incorporates disciplines such as Placebo, Oncology and Cabotegravir in addition to Internal medicine. His Virology research is multidisciplinary, relying on both Reverse transcriptase, Homing, Drug resistance and Genotype.
The Pre-exposure prophylaxis study combines topics in areas such as Young adult, Reproductive health, Cohort and Emtricitabine. His study focuses on the intersection of Cohort and fields such as Human sexuality with connections in the field of Cohort study, Placebo group, Dried blood, Transgender women and Hiv incidence. His Men who have sex with men study combines topics in areas such as Incidence, Randomized controlled trial, Family medicine, Gynecology and Unsafe Sex.
His primary areas of study are Pre-exposure prophylaxis, Internal medicine, Immunology, Virology and Theology. His Pre-exposure prophylaxis study necessitates a more in-depth grasp of Men who have sex with men. He interconnects Young adult, Demography, Serostatus, Gynecology and Public health in the investigation of issues within Men who have sex with men.
His research integrates issues of Placebo and Oncology in his study of Internal medicine. His Immunology study integrates concerns from other disciplines, such as Acquired immunodeficiency syndrome and Drug resistance. The concepts of his Virology study are interwoven with issues in Protease inhibitor and Reverse transcriptase.
Pre-exposure prophylaxis, Men who have sex with men, Emtricitabine, Internal medicine and Family medicine are his primary areas of study. His Pre-exposure prophylaxis research incorporates elements of Clinical trial, Tenofovir, Randomized controlled trial, Public health and Drug resistance. He interconnects Regimen, Acquired immunodeficiency syndrome and Immunology in the investigation of issues within Drug resistance.
His studies in Men who have sex with men integrate themes in fields like Cross-sectional study, Demography, Gynecology, Pill and Cohort. The Emtricitabine study combines topics in areas such as Condom, Placebo, Drug detection and Incidence. His work carried out in the field of Family medicine brings together such families of science as Alternative medicine and Context.
Robert M. Grant mainly focuses on Pre-exposure prophylaxis, Emtricitabine, Internal medicine, Men who have sex with men and Randomized controlled trial. His research in Pre-exposure prophylaxis intersects with topics in Condom, Clinical trial, Reproductive health, Public health and Drug resistance. His biological study spans a wide range of topics, including Incidence, Risk compensation, Gynecology, Seroconversion and Pharmacology.
His study ties his expertise on Surgery together with the subject of Internal medicine. His Men who have sex with men research incorporates themes from Cohort and Intensive care medicine. The study incorporates disciplines such as Placebo, Family medicine and Dosing in addition to Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M. Grant;Javier R. Lama;Peter L. Anderson;Vanessa McMahan.
The New England Journal of Medicine (2010)
Preexposure Prophylaxis for HIV Infection among African Women
Lut Van Damme;Amy Corneli;Khatija Ahmed;Johan Lombaard.
The New England Journal of Medicine (2012)
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Robert M. Grant;Robert M. Grant;Robert M. Grant;Peter L. Anderson;Vanessa McMahan;Albert Liu.
Lancet Infectious Diseases (2014)
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.
Peter L. Anderson;David V. Glidden;Albert Liu;Susan Buchbinder.
Science Translational Medicine (2012)
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
Steven G. Deeks;Terri Wrin;Teri Liegler;Rebecca Hoh.
The New England Journal of Medicine (2001)
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.
Virginia A. Fonner;Sarah L. Dalglish;Caitlin E. Kennedy;Rachel Baggaley.
Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis
Laura A. Napolitano;Robert M. Grant;Steven G. Deeks;Diane Schmidt.
Nature Medicine (2001)
Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study.
Warren Winkelstein;David M. Lyman;Nancy Padian;Robert Grant.
Time trends in primary HIV-1 drug resistance among recently infected persons.
Robert M. Grant;Frederick M. Hecht;Maria Warmerdam;Lea Liu.
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.
Kim S. Erlich;John Mills;Pamela Chatis;Gregory J. Mertz.
The New England Journal of Medicine (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: